The Long-COVID Syndrome represents a significant emotional and financial burden to patients, their families and society.
It has been recently estimated that 2% of 35-49 year olds in the UK have Long-COVID and have been out of work longer than 12 months. This webinar aims to update us on susceptibility and risk factors associated with enhanced risk for Long -COVID and therapeutically – what clinical trials are in the pipeline that potentially address reducing the risk of disease and in patients with this syndrome, improve the symptoms of this disabling condition.
Register here.